149 Stories, most recent news story added Fri Nov 27, 12:00 pm ET
WHO warns countries to stay on guard for H5N1 threats The World Health Organization (WHO) today warned that recently confirmed cases of H5N1 avian influenza in poultry in Egypt, Indonesia, Thailand, and Vietnam serve as a reminder that the virus is still a threat to humans.
After a lethal bird flu virus emerged in Asia, U.S. officials launched an intense effort to build new defenses against a pandemic, including replacing an antiquated vaccine system, which depends on millions of chicken eggs.
Biotech firm Replikins Ltd. today issued its latest biochemical analysis of the H1N1 virus genomic data. It shows that the lethality of the virus has dropped from its peak of 3.7 (s.d. 4.5) during the virus's current outbreak in the spring of 2009 to resting non-epidemic levels this week of 2.0 (s.d. 0.1). The H1N1 infectivity count, however, remains increased.
Controlling an outbreak of H5N1 Avian Flu, SARS, or BSE is becoming a reality thanks to patentable tracking technologies emerging from AgroMicron, Ltd. [PR.com - September 02, 2006]
Medicago Inc. , a biotechnology company focused on developing highly effective and affordable vaccines based on proprietary manufacturing technologies and Virus-Like Particles, today announced its operational and financial results for the third quarter ended September 30, 2009.
Why mall Santas do need the H1N1 vaccine.
BOSTON, Nov. 25 /PRNewswire/ -- Biotech firm Replikins Ltd., which has analyzed the H1N1 virus' genomic data from the 1918 pandemic through the prediction, outbreak, and progress of the current H1N1 pandemic, today issued its latest biochemical analysis of the virus.
BEIJING, Nov. 25 /PRNewswire-Asia/ -- Sinovac Biotech Ltd.
Reportlinker.com announces that a new market research report is available in its catalogue:
HOLLY SPRINGS, N.C. -(Dow Jones)- Swiss drug maker Novartis AG (NVS, NOVN.VX) opened a vaccine-manufacturing plant Tuesday designed to make influenza vaccines without relying on decades-old technology that employs millions of chicken eggs to grow viruses.
Nov 24, 2009 (CIDRAP News) – The era of cell-based influenza vaccine production in the United States seemed to move closer today as Novartis unveiled its new, nearly billion-dollar manufacturing plant in Holly Springs, N.C., but onshore production and marketing of cell-based vaccines remains a few years away.
GlaxoSmithKline (GSK) today announced that over 40 million doses of its adjuvanted pandemic H1N1 vaccine have been distributed to countries globally for use in government-initiated vaccination programmes.
Cover your sneezes. Stay home if you are sick. Wash those hands. -- read more
LOMA LINDA - If there's a lesson to be learned from the H1N1 influenza virus, it is that the nation's vaccine production must be modernized, a top public-health official said here Monday.
Sinovac Biotech Ltd. , a leading provider of biopharmaceutical products in China, announced today that management is scheduled to present at the Piper Jaffray Health Care Conference on Wednesday, December 2, 2009 at 8 a.m.
New methods of studying avian influenza strains and visually mapping their movement around the world will help scientists more quickly learn the behavior of the pandemic H1N1 flu virus, Ohio State University researchers say. The researchers linked many powerful computer systems together to analyze enormous amounts of genetic data collected from all publicly available isolated strains of the H5N1 ...
